1. Home
  2. CPIX vs EEA Comparison

CPIX vs EEA Comparison

Compare CPIX & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • EEA
  • Stock Information
  • Founded
  • CPIX 1999
  • EEA 1986
  • Country
  • CPIX United States
  • EEA Germany
  • Employees
  • CPIX N/A
  • EEA N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • EEA Trusts Except Educational Religious and Charitable
  • Sector
  • CPIX Health Care
  • EEA Finance
  • Exchange
  • CPIX Nasdaq
  • EEA Nasdaq
  • Market Cap
  • CPIX 68.7M
  • EEA 57.7M
  • IPO Year
  • CPIX 2009
  • EEA N/A
  • Fundamental
  • Price
  • CPIX $4.73
  • EEA $9.86
  • Analyst Decision
  • CPIX
  • EEA
  • Analyst Count
  • CPIX 0
  • EEA 0
  • Target Price
  • CPIX N/A
  • EEA N/A
  • AVG Volume (30 Days)
  • CPIX 44.3K
  • EEA 9.2K
  • Earning Date
  • CPIX 08-05-2025
  • EEA 01-01-0001
  • Dividend Yield
  • CPIX N/A
  • EEA 1.92%
  • EPS Growth
  • CPIX N/A
  • EEA N/A
  • EPS
  • CPIX N/A
  • EEA N/A
  • Revenue
  • CPIX $41,083,299.00
  • EEA N/A
  • Revenue This Year
  • CPIX N/A
  • EEA N/A
  • Revenue Next Year
  • CPIX N/A
  • EEA N/A
  • P/E Ratio
  • CPIX N/A
  • EEA N/A
  • Revenue Growth
  • CPIX 5.82
  • EEA N/A
  • 52 Week Low
  • CPIX $1.04
  • EEA $7.45
  • 52 Week High
  • CPIX $7.25
  • EEA $9.26
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 50.35
  • EEA 50.51
  • Support Level
  • CPIX $5.11
  • EEA $9.90
  • Resistance Level
  • CPIX $5.88
  • EEA $10.18
  • Average True Range (ATR)
  • CPIX 0.41
  • EEA 0.12
  • MACD
  • CPIX -0.05
  • EEA -0.04
  • Stochastic Oscillator
  • CPIX 37.67
  • EEA 3.03

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About EEA The European Equity Fund Inc.

European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.

Share on Social Networks: